BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30553016)

  • 1. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
    Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
    Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
    Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells.
    Mitkin NA; Hook CD; Schwartz AM; Biswas S; Kochetkov DV; Muratova AM; Afanasyeva MA; Kravchenko JE; Bhattacharyya A; Kuprash DV
    Sci Rep; 2015 Mar; 5():9330. PubMed ID: 25786345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
    Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
    Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
    Panse J; Friedrichs K; Marx A; Hildebrandt Y; Luetkens T; Barrels K; Horn C; Stahl T; Cao Y; Milde-Langosch K; Niendorf A; Kröger N; Wenzel S; Leuwer R; Bokemeyer C; Hegewisch-Becker S; Atanackovic D
    Br J Cancer; 2008 Sep; 99(6):930-8. PubMed ID: 18781150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
    Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
    Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
    Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
    J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
    Pimenta EM; De S; Weiss R; Feng D; Hall K; Kilic S; Bhanot G; Ganesan S; Ran S; Barnes BJ
    Immunol Cell Biol; 2015; 93(5):486-99. PubMed ID: 25533286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
    Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
    Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
    Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
    Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
    Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
    Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13/CXCR5 signaling axis in cancer.
    Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
    Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.
    Zhu Z; Zhang X; Guo H; Fu L; Pan G; Sun Y
    Mol Cell Biochem; 2015 Feb; 400(1-2):287-95. PubMed ID: 25476740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL13/CXCR5 are potential biomarkers for diagnosis and prognosis for breast cancer.
    Jiang L; Wang D; Sheng M; Tong D; Liu H; Dong L; Ma J
    J BUON; 2020; 25(6):2552-2561. PubMed ID: 33455096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia.
    Shiao YM; Lee CC; Hsu YH; Huang SF; Lin CY; Li LH; Fann CS; Tsai CY; Tsai SF; Chiu HC
    J Neuroimmunol; 2010 Apr; 221(1-2):101-6. PubMed ID: 20223524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.
    Qi XW; Xia SH; Yin Y; Jin LF; Pu Y; Hua D; Wu HR
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1916-24. PubMed ID: 25010623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.
    Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G
    EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice.
    Zhang Q; Cao DL; Zhang ZJ; Jiang BC; Gao YJ
    J Neuroinflammation; 2016 Jul; 13(1):183. PubMed ID: 27401148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.